Going digital is not about Social media or Omni channels. Is it about asking simple questions. Best Buy is one of the largest electronic good retailers in USA. Few years ago Best Buy was threatened by what is now known as Showrooming effect. Basically customers would walk into its showrooms get benefitted by the advice of the salesperson, decide on the model and then go online to buy the product on Amazon because of low prices. Despite having one the best footfalls in the decade Best Buy recorded reduced profits. Although it did try to Price match Amazon they knew it was not a long-term solution because of its cost structure (Physical showrooms, salespeople etc). They couldn’t block the customers from checking price of product on Amazon. Future looked uncertain, everyone thought game over for Best Buy which was the case with many other retailing giants. No amount of investing new technology would have helped Best Buy . Best Buy relearned how to make profits. Best Buy proposed to the manufacturers that they compensate Best Buy for exclusive showcasing of manufacturers new products. Manufacturers also could launch specific brand kiosks within Best Buy showroom for a fee. This new model which had zero investment for Best Buy dramatically increased its profitability. Is this a ground breaking innovation? Of course NO. This has already been practiced in other industries but for the first time tried in Electronic good Retail. Best Buy realized apart from consumers it created lot of value for manufacturers therefore it captured the value lost from consumers from manufacturers. What is my business? What is my business ecosystem? How do I currently make money? How changing one thing impacts my ecosystem? What are the options available?

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Contact Us
Terms of Service
Privacy Statement

Facebook

Twitter

Youtube

Healthcare Trends

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

The Wealth of Pharma Nations: Top 25 Pharma Blockbusters

The economic footprint of a truly historic pharmaceutical blockbuster...

Oxytocin Maternal Deaths in Kota: Death in a Vial

When a vial contains only water, the failure is...

Innovation Without Access to Millions of Poor People is Unethical

What the Trikafta Stand-Off Teaches Us About the Future...

Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics

Dr. Rishubh Gupta has been appointed Head of Subregion...

Marketing

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

The Wealth of Pharma Nations: Top 25 Pharma Blockbusters

The economic footprint of a truly historic pharmaceutical blockbuster...

Oxytocin Maternal Deaths in Kota: Death in a Vial

When a vial contains only water, the failure is...

Innovation Without Access to Millions of Poor People is Unethical

What the Trikafta Stand-Off Teaches Us About the Future...

Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics

Dr. Rishubh Gupta has been appointed Head of Subregion...

Policies/Sales

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

The Wealth of Pharma Nations: Top 25 Pharma Blockbusters

The economic footprint of a truly historic pharmaceutical blockbuster...

Oxytocin Maternal Deaths in Kota: Death in a Vial

When a vial contains only water, the failure is...

Innovation Without Access to Millions of Poor People is Unethical

What the Trikafta Stand-Off Teaches Us About the Future...

Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics

Dr. Rishubh Gupta has been appointed Head of Subregion...

Strategy

Simon Rosof has been appointed Head of Asia Pacific for Bayer Pharmaceuticals

Simon Rosof has been appointed Head of Asia Pacific...

The Wealth of Pharma Nations: Top 25 Pharma Blockbusters

The economic footprint of a truly historic pharmaceutical blockbuster...

Oxytocin Maternal Deaths in Kota: Death in a Vial

When a vial contains only water, the failure is...

Innovation Without Access to Millions of Poor People is Unethical

What the Trikafta Stand-Off Teaches Us About the Future...

Dr. Rishubh Gupta has been appointed Head of Subregion Africa for Roche Diagnostics

Dr. Rishubh Gupta has been appointed Head of Subregion...

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
- FFE+CEO RT
- BrandStorm
Solutions & Pricing
Partner

Hot topics

What Leadership is Not! Position, Authority, or Activity

Leadership is not Measured by Position, Authority, or Activity. It...

Pharma GCCs in India — Hype, Reality & What’s Next?

Part 1: Pharma GCCs in India — Orange Markets...

Key Highlights: Major Indian Pharma Companies – July 2025

Aurobindo Pharma Limited Began sales to Europe through its China-based...

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs...

Don’t Do Digital for the Sake of Doing Digital

Catalyzed by the pandemic, the pharma industry quickly progressed from being digitally agnostic to a state of preparedness. The shift required the industry to experiment with technology in its customer-facing plans, which resulted in many cases the creation of random acts of digital, often without a cohesive overarching strategy. Can pharma do better? The answer lies in understanding the utility of their digital assets while building a mindset to transform, and ensuring that teams within the organization do not work at cross-purposes.